Reasons for buying:
Buy PE was reasonable at 11.02 and below 10 years PE median of 12.45.
Earnings have increased close to 4 times since 2012.
Return on equity is good at 18.49%.
The market cap of the company is ₹254.34cr.
The debt of the company is ₹3.71cr with ₹56.76cr in cash.
Buy date: 19-Oct-2021
Qty: 20 Buy Price: ₹484 Buy EPS: 43.9 Buy PE: 11.02
The price of the stock is up about 15.05% from my buy price.
The company is engaged in the manufacture of pharmaceutical formulations.
No comments:
Post a Comment